Literature DB >> 29406494

Approval of first tumor gene panel sends shockwaves through labs.

Mark Ratner.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29406494     DOI： 10.1038/nbt0218-124

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  FDA pushes for control over laboratory-developed tests.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2014-09       Impact factor: 54.908
  1 in total
  2 in total

1.  Next-generation sequencing tests to become routine.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2018-06-06       Impact factor: 54.908

2.  Roche splashes $2.4 billion on Foundation Medicine's cancer platform.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2018-09-06       Impact factor: 54.908
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.